CBSC activates China manufacturing pipeline and advances MyCardia AT into final NMPA submission phase with Ebulent Medical.

Jan 15

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案激活MyCardia AT中国生产流程并进入NMPA最终申报阶段

CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.

Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

Sep 04

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案(CBSC)签署覆盖中美洲和南美洲的独家五年分销协议

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

How can we help you?

Tell us what you are interested in.

Contact Us

订阅我们的新闻邮件！

订阅我们的电子报，我们将直接向您发送最新消息。